Evidence map›Paper›PMID 36771229›Full record

ArticleNutrients2023

Rectus Femoris Muscle and Phase Angle as Prognostic Factor for 12-Month Mortality in a Longitudinal Cohort of Patients with Cancer (AnyVida Trial).

Cristina García-García, Isabel María Vegas-Aguilar, Rosalía Rioja-Vázquez, Isabel Cornejo-Pareja, Francisco J Tinahones, José Manuel García-Almeida

Abstract read
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cristina García-GarcíaFacultad de Medicina, Universidad of Málaga, 29010 Málaga, Spain.ORCID 0000-0002-1311-9970
Isabel María Vegas-AguilarUnidad de Gestión Clínica en Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Rosalía Rioja-VázquezUnidad de Gestión Clínica en Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.
Isabel Cornejo-ParejaUnidad de Gestión Clínica en Endocrinología y Nutrición, Hospital Universitario Virgen de la Victoria, 29010 Málaga, Spain.ORCID 0000-0002-8664-8697
Francisco J TinahonesFacultad de Medicina, Universidad of Málaga, 29010 Málaga, Spain.
José Manuel García-AlmeidaFacultad de Medicina, Universidad of Málaga, 29010 Málaga, Spain.ORCID 0000-0001-8570-184X

Funding

Instituto de Salud Carlos III (CM 17/00169), (JR 19/00054)
6 · The paper itself

Abstract

backgroundCancer-related malnutrition is still unrecognized and undertreated in clinical practice. The morphofunctional assessment of disease-related malnutrition (DRM) is a new approach that focuses on evaluating changes in body composition and function. The aim of this study is to evaluate the prognostic value of classic and emerging assessment of malnutrition at 12-months survival in cancer patients.

methodsWe conducted a prospective study on cancer outpatients. Bioelectrical impedance with phase angle (PhA), nutritional ultrasound by rectus femoris cross-sectional area (RFCSA), hand grip strength, and "Timed Up and Go Test" (TUG) were evaluated as predictors of mortality.

resultsFifty-seven patients were included. The non-survivors had lower PhA values than the survivors (4.7° vs. 5.4°;

conclusionsLow PhA and RFCSA values are significant independent predictors of mortality in cancer patients. These cut-off points are clinical data that can be used for nutritional assessment and the prediction of clinical outcomes.

Indexed as

MalnutritionNeoplasmsElectric ImpedanceFemaleHand StrengthHumansMaleNutritional StatusPrognosisProspective StudiesQuadriceps Musclebioelectrical impedancecancerdisease-related malnutritionmortalityphase anglerectus femoris muscle

Identifiers

PMID36771229
PMCPMC9919732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.